Citation

Zak M, Hanan EJ, Lupardus P, Brown DG, Robinson C, Siu M, Lyssikatos JP, Romero FA, Zhao G, Kellar T, Mendonca R, Ray NC, Goodacre SC, Crackett PH, McLean N, Hurley CA, Yuen PW, Cheng YX, Liu X, Liimatta M, Kohli PB, Nonomiya J, Salmon G, Buckley G, Lloyd J, Gibbons P, Ghilardi N, Kenny JR, Johnson A.: Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling. Bioorg Med Chem Lett, Volume 29 (12), 2019

Authors

Brown DG, Buckley G, Cheng YX, Crackett PH, Ghilardi N, Gibbons P, Goodacre SC, Hanan EJ, Hurley CA, Johnson A., Kellar T, Kenny JR, Kohli PB, Liimatta M, Liu X, Lloyd J, Lupardus P, Lyssikatos JP, McLean N, Mendonca R, Nonomiya J, Ray NC, Robinson C, Romero FA, Salmon G, Siu M, Yuen PW, Zak M, Zhao G

Journal

Bioorg Med Chem Lett

Year

2019

DOI

10.1016/j.bmcl.2019.04.008

PubMed

30981576

Machine-readable

REST APIRDF